ALCAM and colorectal carcinoma: In a contradictory manner, high CD166 expression has been associated with significantly longer OS and disease-free survival compared to cases exhibiting lower CD166 expression (p = 0.040 vs. p = 0.044), as seen in another study on 94 CRC patients [53].